Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Wnt-5a Protein | 1 | 2019 | 14 | 0.80 | Why? |
| Fatty Acids, Omega-3 | 3 | 2018 | 306 | 0.77 | Why? |
| Environmental Pollution | 1 | 2020 | 344 | 0.64 | Why? |
| Fibronectins | 1 | 2017 | 92 | 0.63 | Why? |
| Cholecalciferol | 1 | 2019 | 246 | 0.60 | Why? |
| Insulin Resistance | 1 | 2019 | 669 | 0.51 | Why? |
| Cholesterol, LDL | 1 | 2017 | 499 | 0.49 | Why? |
| Dietary Supplements | 6 | 2019 | 2251 | 0.48 | Why? |
| Diabetes Mellitus, Experimental | 3 | 2019 | 192 | 0.47 | Why? |
| Mothers | 1 | 2020 | 1624 | 0.39 | Why? |
| Hexuronic Acids | 2 | 2018 | 11 | 0.38 | Why? |
| Ubiquinone | 2 | 2019 | 91 | 0.37 | Why? |
| Dyspnea | 2 | 2020 | 3847 | 0.34 | Why? |
| Migraine Disorders | 3 | 2019 | 530 | 0.34 | Why? |
| Eicosapentaenoic Acid | 2 | 2018 | 106 | 0.33 | Why? |
| C-Reactive Protein | 3 | 2020 | 7972 | 0.32 | Why? |
| Vitamin D | 2 | 2019 | 2904 | 0.32 | Why? |
| Neuroprotective Agents | 2 | 2019 | 240 | 0.30 | Why? |
| Diabetes Mellitus, Type 2 | 4 | 2019 | 6166 | 0.29 | Why? |
| Hypoxia | 1 | 2020 | 3626 | 0.29 | Why? |
| Double-Blind Method | 7 | 2019 | 5988 | 0.26 | Why? |
| Fever | 1 | 2020 | 7795 | 0.25 | Why? |
| Curcumin | 2 | 2019 | 396 | 0.25 | Why? |
| Coronary Artery Disease | 1 | 2017 | 2570 | 0.23 | Why? |
| Oxidants, Photochemical | 1 | 2020 | 27 | 0.22 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.22 | Why? |
| Tracheobronchomegaly | 1 | 2020 | 11 | 0.22 | Why? |
| Bottle Feeding | 1 | 2020 | 28 | 0.21 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.21 | Why? |
| Water Pollution | 1 | 2020 | 51 | 0.21 | Why? |
| Infant Formula | 1 | 2020 | 64 | 0.20 | Why? |
| Tachypnea | 1 | 2020 | 197 | 0.20 | Why? |
| Scavenger Receptors, Class A | 1 | 2018 | 26 | 0.19 | Why? |
| Tachycardia | 1 | 2020 | 239 | 0.19 | Why? |
| CD36 Antigens | 1 | 2018 | 44 | 0.18 | Why? |
| Diabetic Cardiomyopathies | 1 | 2019 | 79 | 0.18 | Why? |
| Insulin | 2 | 2018 | 1316 | 0.18 | Why? |
| Resistin | 1 | 2017 | 16 | 0.18 | Why? |
| Scavenger Receptors, Class E | 1 | 2018 | 50 | 0.18 | Why? |
| Antioxidants | 2 | 2019 | 1593 | 0.18 | Why? |
| Erythrocyte Membrane | 1 | 2017 | 56 | 0.18 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 1454 | 0.18 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.17 | Why? |
| Iran | 3 | 2020 | 5467 | 0.17 | Why? |
| Blood Glucose | 4 | 2019 | 3642 | 0.17 | Why? |
| Vitamin B Complex | 1 | 2017 | 49 | 0.17 | Why? |
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 198 | 0.17 | Why? |
| Fatty Acids | 1 | 2017 | 238 | 0.16 | Why? |
| Anthropometry | 1 | 2017 | 233 | 0.15 | Why? |
| Vitamin B 12 | 1 | 2017 | 132 | 0.15 | Why? |
| Carcinoma, Basal Cell | 1 | 2017 | 144 | 0.15 | Why? |
| Fluid Therapy | 1 | 2020 | 628 | 0.15 | Why? |
| Chemokine CCL2 | 1 | 2017 | 389 | 0.15 | Why? |
| Aorta | 1 | 2018 | 355 | 0.14 | Why? |
| Cardiotonic Agents | 1 | 2018 | 418 | 0.14 | Why? |
| Infant, Premature | 1 | 2020 | 883 | 0.14 | Why? |
| Sewage | 1 | 2020 | 591 | 0.14 | Why? |
| Renal Insufficiency | 1 | 2021 | 810 | 0.13 | Why? |
| Myocytes, Cardiac | 1 | 2019 | 804 | 0.12 | Why? |
| Ozone | 1 | 2020 | 757 | 0.12 | Why? |
| Antigens, CD | 1 | 2018 | 984 | 0.12 | Why? |
| Rats, Sprague-Dawley | 3 | 2019 | 987 | 0.11 | Why? |
| Lipids | 1 | 2017 | 1079 | 0.10 | Why? |
| Breast Feeding | 1 | 2020 | 1585 | 0.10 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.09 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.09 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.09 | Why? |
| Feeding Behavior | 1 | 2020 | 1909 | 0.09 | Why? |
| Sample Size | 2 | 2021 | 518 | 0.08 | Why? |
| Rats | 3 | 2019 | 2764 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Analysis of Variance | 2 | 2021 | 950 | 0.08 | Why? |
| Male | 16 | 2021 | 367725 | 0.08 | Why? |
| Transcriptome | 1 | 2019 | 3466 | 0.08 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.07 | Why? |
| Hypoglycemic Agents | 1 | 2018 | 2165 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.07 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.07 | Why? |
| Humans | 21 | 2021 | 930598 | 0.07 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.06 | Why? |
| Models, Statistical | 1 | 2021 | 5312 | 0.06 | Why? |
| Virus Diseases | 1 | 2021 | 3779 | 0.06 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.06 | Why? |
| Inflammation | 3 | 2020 | 13255 | 0.06 | Why? |
| Biomarkers | 4 | 2019 | 23361 | 0.06 | Why? |
| Air Pollution | 1 | 2020 | 3504 | 0.06 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| United Kingdom | 1 | 2020 | 18046 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.05 | Why? |
| Glycated Hemoglobin A | 2 | 2018 | 1316 | 0.05 | Why? |
| Interleukin-6 | 1 | 2018 | 7522 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Palmitic Acid | 1 | 2017 | 28 | 0.05 | Why? |
| Stearic Acids | 1 | 2017 | 30 | 0.04 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.04 | Why? |
| Aryldialkylphosphatase | 1 | 2017 | 61 | 0.04 | Why? |
| Infant | 1 | 2020 | 30274 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Middle Aged | 7 | 2020 | 270681 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Adiponectin | 1 | 2017 | 123 | 0.04 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.04 | Why? |
| Trachea | 1 | 2020 | 894 | 0.04 | Why? |
| Diet | 2 | 2017 | 2052 | 0.04 | Why? |
| Lung | 2 | 2020 | 31049 | 0.03 | Why? |
| Adult | 7 | 2020 | 244371 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Down-Regulation | 1 | 2019 | 1416 | 0.03 | Why? |
| Fasting | 1 | 2018 | 555 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2020 | 1887 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Basic Reproduction Number | 1 | 2021 | 2676 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| Case-Control Studies | 2 | 2017 | 17671 | 0.02 | Why? |
| Oxidative Stress | 1 | 2019 | 2050 | 0.02 | Why? |
| Aged | 3 | 2018 | 215776 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Animals | 3 | 2019 | 78931 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Masks | 1 | 2021 | 8528 | 0.01 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
Javanbakht's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(77)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_